'Naive patients' presentation slideshows

Supported by an unrestricted educational grant from

44th ICAAC. ANTIRETROVIRAL TREATMENT HIGHLIGHTS. An HIV/AIDS Overview from the 44th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy October 30 - November 2, 2004; Washington, DC. Summarized by Douglas J. Ward, MD, FACP Dupont Circle Physicians Group, Washington, DC.

596 views • 38 slides

Selected and summarized by Joseph J. Eron, Jr, MD

Highlights of the 42 nd Interscience Conference on Antimicrobial Agents and Chemotherapy September 27-30, 2002; San Diego, California. Selected and summarized by Joseph J. Eron, Jr, MD Associate Professor of Medicine University of North Carolina at Chapel Hill.

302 views • 20 slides

Extended Treatment Duration in Chronic Hepatitis C Genotype 1 Infected Slow-Responders: Final Results of the SUCCESS

Extended Treatment Duration in Chronic Hepatitis C Genotype 1 Infected Slow-Responders: Final Results of the SUCCESS Study. M. Buti, Y. Lurie, N.G. Zakharova, N.P. Blokhina, A. Horban, C. Sarrazin, L. Balciuniene, R. Chen, X. Yu, R. Faruqi, R. Esteban.

522 views • 18 slides

Why do clinical development in Canada?

177 views • 10 slides

Trials Accelerating Research : Approaches that Work XVI International Aids Conference

Responsibilities of state, community and private sector on research ethic Policy : looking back on recent CCR5 antagonists Hugues Fischer, TRT-5 (French Cab), Act Up-Paris, Paris, France. Trials Accelerating Research : Approaches that Work XVI International Aids Conference

94 views • 9 slides

Double-blind Study Design

167 views • 1 slides